675
Participants
Start Date
December 22, 2022
Primary Completion Date
March 24, 2023
Study Completion Date
July 7, 2023
TNM002
"Dosage Form: Injection, solution~Route of administration: IM gluteal injection"
Human tetanus immunoglobulin (HTIG)
"Dosage Form: Injection, solution~Route of administration: IM gluteal injection"
Peking University First Hospital, Beijing
Peking University People's Hospital, Beijing
Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing
Hefei First People's Hospital, Hefei
The Second Hospital of Anhui Medical University, Hefei
PKUCare Luzhong Hospital, Zibo
Zhejiang Provincial People's Hospital, Hangzhou
The Second Affiliated Hospital of Nanchang University, Nanchang
The Second Xiangya Hospital of Central South University, Changsha
Affiliated Nanhua Hospital, University of South China, Hengyang
The Central Hospital of Wuhan, Tongji Medical College Huazhong University of Science&Technology, Wuhan
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Renmin Hospital of Wuhan University, Wuhan
Zhongnan Hospital of Wuhan University, Wuhan
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
Guangdong Provincial Hospital of Chinese Medicine, Guangzhou
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou
Guangzhou First People's Hospital, Guangzhou
Nanfang Hospital of Southern Medical University, Guangzhou
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
Shenzhen Second People's Hospital, Shenzhen
Liuzhou Worker's Hospital - Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou
Affiliated Hospital of Zunyi Medical College, Zunyi
Hainan General Hospital, Haikou
General Hospital of Ningxia Medical University, Yinchuan
The First People's Hospital of Jinzhong, Jinzhong
Shanxi Academy of Medical Sciences - Shanxi Bethune Hospital (Shanxi Dayi Hospital), Taiyuan
Yuncheng Central Hospital - East Campus, Yuncheng
Zhuhai Trinomab Pharmaceutical Co., Ltd.
INDUSTRY